Information  X 
Enter a valid email address

Kropz PLC (KRPZ)

  Print   

Friday 15 October, 2021

Kropz PLC

Result of General Meeting

RNS Number : 2650P
Kropz PLC
15 October 2021
 

 

15 October 2021

Kropz Plc
("Kropz" or the "Company")

Result of General Meeting

Kropz plc (AIM: KRPZ), an emerging African phosphate producer, is pleased to announce that all the resolutions put to the General Meeting ("GM") held earlier today, Friday 15 October 2021, were duly passed on a poll. A breakdown of proxy votes lodged prior to the GM and votes cast at the GM will be available shortly on the Company's website.

 

As announced on 29 September 2021, the purpose of the GM was to provide the Company's directors authority to issue and allot, on a non-pre-emptive basis, shares in the Company to meet the full demand under the new ZAR200 million equity facility from the Company's largest shareholder, ARC Fund ("ZAR200 million Equity Facility"). The first drawdown under the ZAR200 million Equity Facility is expected on 25 October 2021.

 

For further information visit   www.kropz.com  or contact:

Kropz Plc


Mark Summers (CEO)

+27 (0)79 744 8708



Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

George Grainger

 

+44 (0) 20 7383 5100

Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

 +44 (0)20 7907 8500


Tavistock

Financial PR & IR (UK)

Nick Elwes

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

[email protected]


R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0)11 880 3924

[email protected] 

About Kropz Plc

Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate mining project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFFLIALELIL

a d v e r t i s e m e n t